Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21.1 - Vaxart, Inc. | ex21-1.htm |
| EX-23 - EXHIBIT 23.1 - Vaxart, Inc. | ex23-1.htm |
| EX-32 - EXHIBIT 32.1 - Vaxart, Inc. | ex32-1.htm |
| EX-31 - EXHIBIT 31.1 - Vaxart, Inc. | ex31-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Vaxart, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Vaxart, Inc. | bota20140630_10k.htm |
Exhibit 23.1a
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-190594) and Form S-8 (No. 333-188111, No. 333-115691, No. 333-115688, No. 333-109017, No. 333-38864, No. 333-38868, No. 333-95269, No. 333-56037, No. 333-56071, No. 033-65069, No. 033-60795, No. 333-134954, No. 333-143238 and No. 333-143239) of Biota Pharmaceuticals, Inc. of our report dated 27 September 2013 relating to the financial statements and the effectiveness of internal control over financial reporting, which appear in this Form 10-K.
/s/ PricewaterhouseCoopers
Melbourne, Australia
30 September 2014